ROME – Many patients with rheumatoid arthritis can reduce – or even discontinue – their

maintenance therapy with tumor necrosis factor inhibitors after they achieve clinical stability.

Half who...

Field of Interest: Rheumatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness